Clinical benefits of extended-release memantine (28 mg, once daily) as a function of disease severity in people with moderate to severe Alzheimer's disease: Post hoc analysis from a randomized trial
Tocco, Michael, Hendrix, Suzanne, Miller, Michael, Pejovic, Vojislav, Graham, StephenVolume:
9
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2013.05.1345
Date:
July, 2013
File:
PDF, 51 KB
english, 2013